Proceedings of the IVth Biennial South African Lymphoma Study Group meeting Cape Town, October 2010
dc.contributor.author | Jacobs P. | |
dc.date.accessioned | 2011-05-15T16:18:15Z | |
dc.date.available | 2011-05-15T16:18:15Z | |
dc.date.issued | 2011 | |
dc.description.abstract | [No abstract available] | |
dc.description.version | Editorial | |
dc.identifier.citation | Transfusion and Apheresis Science | |
dc.identifier.citation | 44 | |
dc.identifier.citation | 2 | |
dc.identifier.issn | 14730502 | |
dc.identifier.other | 10.1016/j.transci.2011.01.011 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/14576 | |
dc.subject | monoclonal antibody | |
dc.subject | monoclonal antibody cd30 | |
dc.subject | rituximab | |
dc.subject | unclassified drug | |
dc.subject | cancer immunotherapy | |
dc.subject | cancer radiotherapy | |
dc.subject | editorial | |
dc.subject | Hodgkin disease | |
dc.subject | human | |
dc.subject | lymphoma | |
dc.subject | South Africa | |
dc.title | Proceedings of the IVth Biennial South African Lymphoma Study Group meeting Cape Town, October 2010 | |
dc.type | Editorial |